Back

Genome-wide analysis of tandem repeat variation identifies SLC15A4 as a susceptibility gene for idiopathic pulmonary fibrosis

Oketch, J. W.; Albahimah, A.; Barca, A.; Allen, R.; Shrine, N.; Walewski, B.; Sidekli, O.; Alyassi, A.; Romano, A.; Jenkins, R. G.; Maher, T.; Molyneaux, P.; Stewart, I.; Verri, T.; Wain, L. V.; Hollox, E. J.

2025-11-27 genetic and genomic medicine
10.1101/2025.11.25.25340948 medRxiv
Show abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal interstitial lung disease with a strong genetic component, yet a substantial proportion of its genetic risk remains unexplained by single-nucleotide variant (SNV) association studies. In this study, we conduct a genome-wide association study of tandem repeats (TRs), which are a pervasive and understudied class of genetic variation, to identify novel loci influencing IPF susceptibility. Using whole-genome sequencing data from two case-control datasets (discovery: 507 cases and 174 controls; replication: 1243 cases and 3197 controls), we identify and replicate associations at four TR loci, most notably a complex repeat within intron 2 of SLC15A4, a gene encoding the endolysosomal peptide-histidine transporter 1 (PHT1). This TR is within a predicted enhancer and acts as an expression and splicing quantitative trait locus (eQTL/sQTL), influencing the expression of an alternative SLC15A4 transcript in biologically-relevant tissues and cells, with longer TR alleles correlating with decreased expression of this alternative transcript and increased IPF risk. In a biologically-relevant cell-line model, we show that this alternative transcript is targeted by nonsense-mediated mRNA decay, and levels of the alternative transcript are inversely correlated with levels of the canonical full-length SLC15A4 transcript. Our findings implicate SLC15A4 in IPF pathogenesis, possibly via modulation of innate immune responses to injury, and demonstrate the power of TR-focused genomic analyses to reveal previously undetectable disease mechanisms and therapeutic targets.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.